Lupin Q2 PAT soars 73% to ₹1,485 crore

Lupin Q2 PAT up ~73% to ₹1,485 cr; generics strength and cost Levers driving rebound.

positive
Recently

Lupin Q2 PAT soars 73% to ₹1,485 crore

1 min read66 words
Lupin Q2 PAT soars 73% to ₹1,485 crore
Lupin Q2 PAT up ~73% to ₹1,485 cr; generics strength and cost Levers driving rebound.
Lupin posted a profit after tax of ₹1,484.8 crore for Q2 FY26, up about 72.8% YoY from ₹859.5 crore in Q2 FY25. 
The robust earnings helped lift its share price by over 2% on the announcement. Commentators highlight the strength of the company’s generic pipeline and cost optimisations as key drivers. 
Lupin’s Q2 PAT jumps ~73% to ₹1,485 cr, highlighting strength in its generics business and cost structure.
Sentinel